FDA Inspection
GenIbet Biopharmaceuticals, S.A.GenIbet Biopharmaceuticals, S.A. – FDA Inspection, Jan 21, 2025
Record Details
This FDA Inspection record concerns GenIbet Biopharmaceuticals, S.A., with an inspection on January 21, 2025, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 4e6121f5-c31c-4c26-bf2d-b6dd39f1a1ea
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1259407
- FDA center
- Biologics
- Project area
- Vaccine, Allergenic, and Live Biotherapeutic Products
FDA Citations
2- 21 CFR 211.198(b)Maintenance of Complaint File
- 21 CFR 211.180(e)(2)Items to cover on annual reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of GenIbet Biopharmaceuticals, S.A.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2023 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for GenIbet Biopharmaceuticals, S.A.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.